These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6820896

  • 1. [Periodic prophylactic bladder instillation (PPI) of mitomycin C].
    Mishina T, Watanabe H, Fujiwara T, Kobayashi T, Maegawa M, Nakao M, Nakagawa S.
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):365-71. PubMed ID: 6820896
    [Abstract] [Full Text] [Related]

  • 2. [Intravesical instillation chemotherapy of anticancer agents including cylocide: studies of prophylactic effects on the recurrence].
    Yasumoto R, Asakawa M, Yoshihara H, Sakamoto W, Iseki T, Nakatani T, Wada S, Kishimoto T, Maekawa M, Nishio S.
    Hinyokika Kiyo; 1990 Apr; 36(4):407-13. PubMed ID: 2116082
    [Abstract] [Full Text] [Related]

  • 3. Early and large-dose intravesical instillation of epirubicin to prevent superficial bladder carcinoma recurrence after transurethral resection.
    Mitsumori K, Tsuchiya N, Habuchi T, Li Z, Akao T, Ohyama C, Sato K, Kato T.
    BJU Int; 2004 Aug; 94(3):317-21. PubMed ID: 15291859
    [Abstract] [Full Text] [Related]

  • 4. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
    Ding GQ, Shen ZJ, Lu J, Jin XD, Chen J, Shi SF.
    Zhonghua Wai Ke Za Zhi; 2005 Nov 15; 43(22):1457-60. PubMed ID: 16318813
    [Abstract] [Full Text] [Related]

  • 5. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT, Yildirim U, Zorlu F, Ozen H.
    J Urol; 2006 May 15; 175(5):1641-4. PubMed ID: 16600720
    [Abstract] [Full Text] [Related]

  • 6. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP, Witjes JA, Oosterhof GO, Debruyne MJ.
    Semin Urol Oncol; 1996 Feb 15; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [Abstract] [Full Text] [Related]

  • 7. [Intravesical instillation with epirubicin as a prophylactic treatment for superficial bladder cancer--using two different schedules].
    Segawa N, Nishida T, Takahara K, Nomi H, Azuma H, Katsuoka Y.
    Hinyokika Kiyo; 2008 Nov 15; 54(11):711-6. PubMed ID: 19068724
    [Abstract] [Full Text] [Related]

  • 8. [Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor].
    Kuroda K, Ishii N, Fukasawa K, Shirai M, Tajima M, Matsushima M, Miura K, Takanami M, Matsuhashi M, Kuwabara T, Matsumoto H, Sugita M.
    Hinyokika Kiyo; 1998 Aug 15; 44(8):547-52. PubMed ID: 9783189
    [Abstract] [Full Text] [Related]

  • 9. [Combination chemotherapy of mitomycin C and cytosine arabinoside in the intravesical treatment for superficial bladder tumors: report 2. Evaluation of prophylactic intravesical infusion therapy].
    Ikeuchi T, Onodera Y, Kai Y.
    Gan To Kagaku Ryoho; 1984 Apr 15; 11(4):858-63. PubMed ID: 6426397
    [Abstract] [Full Text] [Related]

  • 10. Single instillation of mitomycin C reduces 1st year recurrence following transurethral resection of non-muscle invasive bladder cancer.
    Ather MH, Aziz S, Sulaiman MN.
    J Ayub Med Coll Abbottabad; 2007 Apr 15; 19(4):18-20. PubMed ID: 18693589
    [Abstract] [Full Text] [Related]

  • 11. Increasing patient comfort by optimized postoperative administration of intravesical mitomycin C.
    Stoehr B, Mueller T, Granig T, Zangerl F, Steiner H.
    BJU Int; 2008 Dec 15; 102(11):1556-9. PubMed ID: 18691179
    [Abstract] [Full Text] [Related]

  • 12. [Prophylactic effect of pirarubicin (THP) on postoperative recurrence of superficial bladder cancer in terms of intravesical retention time].
    Nonomura N, Nishimura K, Okuyama A, Miki T, Kishimoto T, Kiyohara H, Wakatsuki A, Fujioka H, Kuroda H, Nakano E, Takeyama M, Koide T, Yamaguchi S.
    Hinyokika Kiyo; 2001 May 15; 47(5):315-9. PubMed ID: 11433751
    [Abstract] [Full Text] [Related]

  • 13. [Efficacy and safety of different dosages of intravesical epirubicin instillation for prevention of primary superficial bladder carcinoma from recurrence].
    Wu ZB, Lin GB, Chen BJ, Wu ZM, Rong RM.
    Zhonghua Zhong Liu Za Zhi; 2005 Aug 15; 27(8):507-9. PubMed ID: 16188156
    [Abstract] [Full Text] [Related]

  • 14. [Prevention of postoperative recurrence of bladder cancer: a clinical study].
    Yang D, Li S, Wang H, Li X, Liu S, Han W, Hao J, Zhang H.
    Zhonghua Wai Ke Za Zhi; 1999 Aug 15; 37(8):464-5. PubMed ID: 11829890
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.
    Solsona E, Iborra I, Ricós JV, Monrós JL, Casanova J, Dumont R.
    J Urol; 1999 Apr 15; 161(4):1120-3. PubMed ID: 10081851
    [Abstract] [Full Text] [Related]

  • 16. [Anti-tumor effect of intravesical instillation of mitomycin C combined with cytosine arabinoside].
    Matsuda M, Matsumiya K, Tada Y, Nakano E, Fujioka H, Osafune M, Takaha M, Sonoda T.
    Hinyokika Kiyo; 1984 Sep 15; 30(9):1145-51. PubMed ID: 6441472
    [Abstract] [Full Text] [Related]

  • 17. [Combination chemotherapy of mitomycin C and cytosine arabinoside in superficial bladder tumors. 1. Evaluation of intravesical infusion therapy].
    Ikeuchi T, Onodera Y, Kai Y.
    Gan To Kagaku Ryoho; 1983 Oct 15; 10(10):2145-51. PubMed ID: 6414383
    [Abstract] [Full Text] [Related]

  • 18. [Single instillation of epirubicin for the prophylaxis of recurrent primary superficial bladder carcinoma].
    Liu B, Zhang Y, Wang Z, Ding Q, Chen B, Wang J, Jiang H.
    Zhonghua Wai Ke Za Zhi; 2002 Feb 15; 40(2):112-5. PubMed ID: 11955393
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Randomized study of single instillation of epirubicin for superficial bladder carcinoma: long-term clinical outcomes.
    Liu B, Wang Z, Chen B, Yu J, Zhang P, Ding Q, Zhang Y.
    Cancer Invest; 2006 Mar 15; 24(2):160-3. PubMed ID: 16537185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.